Prospective Comparison of Rectal Misoprostol versus Oxytocin Infusion for Prevention of Post-Caesarean Section Primary Postpartum Hemorrhage
Ozori E. S, Addah A. O, Isa I. A & Oyeyemi. N · International Journal of Research and Reports in Gynaecology · 2022
Background: The drug of choice recommended by the WHO for the prevention of primary postpartum hemorrhage after vaginal or post Caesarean delivery is oxytocin. However, oxytocin is labile in hot tropical climates as in Africa with reduced efficacy. Misoprostol may be an alternati...
Open access
Research Article